PISAPIA, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 1.850
EU - Europa 894
AS - Asia 585
AF - Africa 24
SA - Sud America 6
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.362
Nazione #
US - Stati Uniti d'America 1.825
IT - Italia 544
SG - Singapore 434
CN - Cina 94
DE - Germania 73
FI - Finlandia 56
ES - Italia 44
NL - Olanda 44
GB - Regno Unito 37
IN - India 30
IE - Irlanda 25
CA - Canada 22
CI - Costa d'Avorio 19
UA - Ucraina 19
RU - Federazione Russa 14
FR - Francia 7
PK - Pakistan 6
SE - Svezia 6
HK - Hong Kong 5
JP - Giappone 5
VN - Vietnam 5
AR - Argentina 4
RS - Serbia 4
BE - Belgio 3
HU - Ungheria 3
MX - Messico 3
RO - Romania 3
AU - Australia 2
BR - Brasile 2
GR - Grecia 2
PT - Portogallo 2
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LT - Lituania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 3.362
Città #
Chandler 380
Singapore 375
Santa Clara 126
Naples 113
Millbury 107
Ashburn 103
Lawrence 89
Des Moines 79
Napoli 62
Milan 43
Wilmington 42
Helsinki 40
Valencia 40
Amsterdam 36
Boston 35
Beijing 28
Munich 24
Rome 22
Nanjing 20
Fairfield 19
Ottawa 18
Dublin 12
Princeton 12
Redwood City 11
Kronberg 9
Salerno 9
Falkenstein 8
Houston 8
Lappeenranta 8
Woodbridge 8
Council Bluffs 7
Falls Church 7
Pune 7
Turin 7
Viareggio 7
Bologna 6
Grosseto 6
Karachi 6
Guangzhou 5
Moscow 5
Pagani 5
Seattle 5
Belgrade 4
Brindisi 4
Chieti 4
Cilavegna 4
Dong Ket 4
Florence 4
Frankfurt am Main 4
Hebei 4
London 4
Los Angeles 4
Munro 4
Pomigliano d'Arco 4
Sciacca 4
Berlin 3
Chennai 3
Formia 3
Hangzhou 3
Jiaxing 3
Messina 3
Montalto di Castro 3
Monza 3
Nanchang 3
Norwalk 3
Ronco all'Adige 3
Salt Lake City 3
Santa Maria 3
Shanghai 3
Venezia 3
Washington 3
Atlanta 2
Bagnoli Irpino 2
Boardman 2
Cagliari 2
Caivano 2
Calgary 2
Caserta 2
Castellammare Di Stabia 2
Catania 2
Cava De' Tirreni 2
Cava Manara 2
Cava de' Tirreni 2
Cernobbio 2
Changsha 2
Coyoacán 2
Dallas 2
Edinburgh 2
Ferrara 2
Krefeld 2
Lisbon 2
Man Kok 2
Marano Di Napoli 2
Marigliano 2
Melito Di Napoli 2
Monte Roberto 2
Montello 2
New York 2
Padova 2
Palermo 2
Totale 2.117
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 98
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 58
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 56
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 53
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 52
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 52
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 51
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 47
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 44
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 44
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 43
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 43
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 43
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 43
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 41
Role of Cytomorphology in the Era of Liquid Biopsy 41
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 41
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 41
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 40
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 39
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 38
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 38
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 37
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 37
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 36
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 35
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 35
Circulating tumour cells in predictive molecular pathology: Focus on drug-sensitive assays and 3D culture 35
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 35
Brca1/2 ngs somatic testing in clinical practice: a short report 35
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 34
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 34
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 34
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 34
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 33
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 33
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 33
Methods for actionable gene fusion detection in lung cancer: now and in the future 33
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 33
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 32
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 32
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 31
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 31
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 31
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 31
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 31
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 30
BRAF mutations in lung cancer 30
Predictive molecular pathology in the time of COVID-19 30
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 29
Ancillary Studies for Serous Fluids 29
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 29
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 28
Critical aspects of MSI testing in endometrial cancer: a comparison study 28
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 28
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 28
BRAF: A Two-Faced Janus 28
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 28
Next generation sequencing in cytology 28
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 27
Invited review—next-generation sequencing: a modern tool in cytopathology 27
The role of liquid biopsy in epithelial ovarian cancer: state of the art 26
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 25
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 25
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 25
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 25
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 24
Liquid Biopsy and Lung Cancer 24
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 24
How to prepare cytological samples for molecular testing 23
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 23
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 23
Tumor mutational burden on cytological samples: A pilot study 23
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 23
The evolving landscape of anatomic pathology 22
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 22
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 22
DNA-Based Sequencing Assays 22
Liquid Biopsy from research to clinical practice: focus on Non-Small Cell Lung Cancer 22
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 22
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 22
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 21
The evolving role of liquid biopsy in lung cancer 21
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 21
Osimertinib 21
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 21
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis 20
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 20
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 20
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 19
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 19
The role of emerging biomarkers in the treatment of non-small cell lung cancer: current challenges and the way forward 19
Juggling the COVID-19 pandemic: A cytopathology point of view 19
Clinical Practice Implications: Monitoring Drug Response and Resistance 19
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 19
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 18
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 17
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer 17
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 17
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 17
Totale 3.110
Categoria #
all - tutte 20.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 6 1 52 1 14 27 4
2020/2021275 7 2 4 1 12 69 20 49 31 34 25 21
2021/2022623 42 15 21 9 11 12 16 69 22 51 132 223
2022/2023923 116 58 40 67 125 115 4 107 172 44 58 17
2023/2024713 42 123 50 29 29 37 25 98 22 38 127 93
2024/2025749 204 235 21 22 99 168 0 0 0 0 0 0
Totale 3.593